HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Michael J Pishvaian Selected Research

utomilumab

12/2019A phase Ib study of utomilumab (PF-05082566) in combination with mogamulizumab in patients with advanced solid tumors.
1/2018Phase I Study of Single-Agent Utomilumab (PF-05082566), a 4-1BB/CD137 Agonist, in Patients with Advanced Cancer.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Michael J Pishvaian Research Topics

Disease

50Neoplasms (Cancer)
01/2022 - 07/2002
24Pancreatic Neoplasms (Pancreatic Cancer)
12/2021 - 11/2012
15Adenocarcinoma
11/2020 - 12/2008
5Disease Progression
01/2021 - 11/2012
4Breast Neoplasms (Breast Cancer)
01/2018 - 07/2002
3Colorectal Neoplasms (Colorectal Cancer)
01/2018 - 01/2011
2Neoplasm Metastasis (Metastasis)
01/2021 - 01/2016
2Exanthema (Rash)
11/2020 - 12/2018
2Diarrhea
11/2020 - 12/2018
2Fatigue
12/2018 - 01/2018
2Carcinogenesis
05/2015 - 05/2011
1Pancreatitis
01/2021
1Hematologic Neoplasms (Hematological Malignancy)
11/2020
1Colitis
11/2020
1Fever (Fevers)
11/2020
1Primitive Neuroectodermal Tumors (PNET)
01/2020
1Neuroendocrine Tumors (Neuroendocrine Tumor)
01/2020
1Carcinoid Tumor (Carcinoid)
01/2020
1Genomic Instability
11/2019
1Microsatellite Instability
08/2019
1Aggressive Fibromatosis (Desmoid)
12/2018
1Hypertension (High Blood Pressure)
12/2018
1Margins of Excision
01/2018
1Endometrial Neoplasms (Endometrial Cancer)
08/2017

Drug/Important Bio-Agent (IBA)

9Biomarkers (Surrogate Marker)IBA
01/2022 - 01/2007
9GemcitabineFDA Link
01/2021 - 03/2013
7Proteins (Proteins, Gene)FDA Link
01/2021 - 05/2011
6Poly(ADP-ribose) Polymerase InhibitorsIBA
12/2021 - 01/2014
5Capecitabine (Xeloda)FDA Link
01/2021 - 05/2014
5DNA (Deoxyribonucleic Acid)IBA
11/2019 - 05/2015
5Lapatinib (GW572016)FDA Link
11/2019 - 05/2015
4veliparibIBA
12/2021 - 11/2015
4Fluorouracil (Carac)FDA LinkGeneric
10/2020 - 05/2014
4LigandsIBA
01/2020 - 06/2012
3Pharmaceutical PreparationsIBA
11/2021 - 03/2013
3Phosphotransferases (Kinase)IBA
11/2019 - 12/2015
3Cyclin-Dependent Kinases (cdk Proteins)IBA
01/2017 - 06/2012
3Cetuximab (Erbitux)FDA Link
05/2015 - 01/2011
3ixabepilone (BMS 247550)FDA Link
05/2014 - 12/2012
2Immune Checkpoint InhibitorsIBA
01/2022 - 08/2019
2B7-H1 AntigenIBA
01/2022 - 08/2017
2Oxaliplatin (Eloxatin)FDA LinkGeneric
10/2020 - 03/2017
2pembrolizumabIBA
01/2020 - 08/2017
2ribociclibIBA
01/2020 - 01/2017
2Monoclonal AntibodiesIBA
12/2019 - 08/2017
2utomilumabIBA
12/2019 - 01/2018
2RNA (Ribonucleic Acid)IBA
08/2019 - 03/2017
2PlatinumIBA
01/2019 - 04/2017
2Sorafenib (BAY 43-9006)FDA Link
12/2018 - 11/2015
2Temozolomide (Temodar)FDA LinkGeneric
01/2018 - 11/2015
2Irinotecan (Camptosar)FDA LinkGeneric
03/2017 - 01/2014
2palbociclibIBA
01/2017 - 06/2012
2Growth Factor ReceptorsIBA
12/2015 - 05/2015
2taxaneIBA
01/2014 - 03/2013
1Topoisomerase InhibitorsIBA
12/2021
1Hypoglycemic Agents (Hypoglycemics)IBA
11/2021
1pyrvinium (Vankin)FDA Link
11/2021
1AnthelminticsIBA
11/2021
1Messenger RNA (mRNA)IBA
01/2021
1CytokinesIBA
01/2021
1temsirolimusFDA Link
01/2021
1osteoblast cadherinIBA
01/2021
1Mitogen-Activated Protein Kinase Kinases (MEKs)IBA
01/2021
1idelalisibIBA
11/2020
1Aspartate Aminotransferases (Aspartate Transaminase)IBA
11/2020
1Protein-Lysine 6-Oxidase (Lysyl Oxidase)IBA
01/2020
1EverolimusFDA Link
01/2020
1mogamulizumabIBA
12/2019
1CC ChemokinesIBA
12/2019
1AntibodiesIBA
12/2019
1Bortezomib (Velcade)FDA Link
11/2019
1Proteasome InhibitorsIBA
11/2019
1Tumor Suppressor Protein p14ARF (p14ARF)IBA
10/2019
1Cyclin-Dependent Kinase Inhibitor p16IBA
10/2019
1abemaciclibIBA
10/2019
1poly ADP-ribose glycohydrolaseIBA
01/2019
1Ribonucleotide Reductases (Ribonucleotide Reductase)IBA
01/2019
1Thymidylate SynthaseIBA
01/2019
1Antineoplastic Agents (Antineoplastics)IBA
01/2019
1TabletsIBA
12/2018
1entrectinibIBA
11/2018
1Antimalarials (Antimalarial Agents)IBA
01/2018
1Transaminases (Aminotransferases)IBA
01/2018
1EnzymesIBA
01/2018
1ArtesunateIBA
01/2018
1O(6)-Methylguanine-DNA MethyltransferaseIBA
01/2018
1TensinsIBA
01/2018
1Isocitrate Dehydrogenase (Isocitrate Dehydrogenase (NAD+))IBA
01/2018
1artemisinin (artemisinine)IBA
01/2018
1Phosphoric Monoester Hydrolases (Phosphatases)IBA
01/2018

Therapy/Procedure

27Therapeutics
01/2021 - 08/2010
11Drug Therapy (Chemotherapy)
11/2020 - 12/2008
5Precision Medicine
06/2020 - 06/2017
3Radiotherapy
04/2017 - 11/2012
2Immunotherapy
01/2022 - 08/2019
2Adjuvant Chemotherapy
01/2018 - 05/2014
2Chemoprevention
06/2012 - 03/2011
1Oral Administration
11/2021
1Combination Drug Therapy (Combination Chemotherapy)
01/2021
1Injections
01/2021